Estimaciones de analistas de Wall Street para KALA BIO, Inc. (KALA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 4 |
| Mantener | 6 |
| Venta | 1 |
| Venta fuerte | 0 |
| Analistas totales | 11 |
| Calificación media (1-5) | 0.27 |
Ratios de valoración
| Precio / Valor contable | 0.00 |
| EV / EBITDA | -1.09 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | $6.1M | $6.4M | $11.2M | $3.9M | 0 | 0 | 0 |
| Coste de Ventas | $297000 | $643000 | $955000 | $2.8M | $3.2M | $4.1M | $2.6M | $303000 | $259000 | 0 |
| Beneficio Bruto | -$297000 | -$643000 | -$955000 | $3.2M | $3.2M | $7.1M | $1.3M | -$303000 | -$259000 | 0 |
| I+D | $25.0M | $29.0M | $29.3M | $27.0M | $18.4M | $11.5M | $17.7M | $18.6M | $21.8M | $18.8M |
| Generales y Administrativos | $7.3M | $10.2M | $34.5M | $64.5M | $81.1M | $105.1M | $65.0M | $20.3M | $18.3M | $23.6M |
| Gastos Operativos | $32.4M | $39.2M | $63.8M | $91.5M | $99.4M | $116.6M | $82.7M | $38.9M | $40.2M | $39.2M |
| Beneficio Operativo | -$32.7M | -$39.9M | -$64.7M | -$88.2M | -$96.2M | -$109.4M | -$81.4M | -$39.2M | -$40.4M | -$39.2M |
| EBITDA | -$32.4M | -$39.2M | -$63.8M | -$85.6M | -$93.4M | -$132.0M | -$36.7M | -$36.1M | -$32.5M | -$23.4M |
| Gastos por Intereses | $767000 | $1.0M | $3.3M | $8.5M | $8.6M | $8.4M | $7.3M | $5.8M | $5.8M | $3.3M |
| Beneficio Antes de Impuestos | -$33.2M | -$42.2M | -$66.7M | -$94.3M | -$104.3M | -$142.6M | -$44.8M | -$42.2M | -$38.5M | -$27.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$33.2M | -$42.2M | -$66.7M | -$94.3M | -$104.3M | -$142.6M | -$44.8M | -$42.2M | -$38.5M | -$27.0M |
| BPA | $-95.95 | $-99.20 | $-124.73 | $-138.00 | $-99.50 | $-108.32 | $-1474.00 | $-867.50 | $-507.50 | $-165.50 |
| BPA Diluido | $-95.95 | $-99.20 | $-124.73 | $-138.00 | $-99.50 | $-108.32 | $-1474.00 | $-867.50 | $-507.50 | $-165.50 |
| Acciones en Circulación (Diluidas) | $345667 | $425499 | $535078 | $684195 | $1.0M | $1.3M | $30412 | $48640 | $75920 | $162965 |
Precio
| Precio | $0.52 |
| Capitalización | $10M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABP · AIM · CANF · ENSC · IBO · KTTA · OGEN
Explorar sector: Healthcare · Biotechnology
Más secciones de KALA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones